MAI Capital Management Has $857,000 Stock Position in Globe Life Inc. $GL

MAI Capital Management lifted its holdings in Globe Life Inc. (NYSE:GLFree Report) by 7,213.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,997 shares of the company’s stock after purchasing an additional 5,915 shares during the period. MAI Capital Management’s holdings in Globe Life were worth $857,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of GL. Waddell & Associates LLC acquired a new position in Globe Life during the third quarter worth $246,000. Mufg Securities Americas Inc. boosted its stake in shares of Globe Life by 19.5% during the 3rd quarter. Mufg Securities Americas Inc. now owns 2,185 shares of the company’s stock worth $312,000 after acquiring an additional 356 shares in the last quarter. Compound Planning Inc. boosted its stake in shares of Globe Life by 8.4% during the 3rd quarter. Compound Planning Inc. now owns 1,886 shares of the company’s stock worth $270,000 after acquiring an additional 146 shares in the last quarter. Clearstead Advisors LLC increased its holdings in shares of Globe Life by 1.9% during the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after acquiring an additional 100 shares during the last quarter. Finally, Koshinski Asset Management Inc. bought a new position in shares of Globe Life in the 3rd quarter valued at approximately $489,000. 81.61% of the stock is currently owned by institutional investors.

Globe Life Price Performance

NYSE:GL opened at $145.32 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The company has a fifty day moving average price of $141.88 and a 200 day moving average price of $138.72. The stock has a market cap of $11.43 billion, a P/E ratio of 10.32 and a beta of 0.46.

Globe Life (NYSE:GLGet Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is currently 7.67%.

Key Globe Life News

Here are the key news stories impacting Globe Life this week:

Insider Buying and Selling

In related news, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the transaction, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. This represents a 25.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 73,868 shares of company stock worth $10,700,437. 1.97% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on GL shares. JPMorgan Chase & Co. upped their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. TD Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $171.33.

Check Out Our Latest Analysis on Globe Life

Globe Life Profile

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Read More

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.